Icad Fundamentals

ICAD
 Stock
  

USD 3.44  0.03  0.88%   

Icad Inc fundamentals help investors to digest information that contributes to Icad's financial success or failures. It also enables traders to predict the movement of Icad Stock. The fundamental analysis module provides a way to measure Icad's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Icad stock.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
  
Icad Research and Development Expense is projected to increase significantly based on the last few years of reporting. The past year's Research and Development Expense was at 9.19 Million. The current year Income Tax Expense is expected to grow to 1,026, whereas Consolidated Income is forecasted to decline to (12.1 M).

Icad Cash and Equivalents Analysis

Icad's Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.

Icad Cash and Equivalents

27.77 Million

Cash 
 = 
Bank Deposits 
+  
Liquidities 
More About Cash and Equivalents | All Equity Analysis

Current Icad Cash and Equivalents

    
  29.8 M  
Most of Icad's fundamental indicators, such as Cash and Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Icad Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Icad Cash and Equivalents Historical Pattern

Today, most investors in Icad Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Icad's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's cash and equivalents growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Icad cash and equivalents as a starting point in their analysis.
   Icad Cash and Equivalents   
Share
       Timeline  
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
Compare to competition

Icad Cash and Equivalents

Cash and Equivalents

27.77 Million

Icad Cash and Equivalents is projected to increase significantly based on the last few years of reporting. The past year's Cash and Equivalents was at 34.28 Million
In accordance with the recently published financial statements, Icad Inc has 29.8 M in Cash and Equivalents. This is 96.37% lower than that of the Healthcare sector and 94.66% lower than that of the Medical Devices industry. The cash and equivalents for all United States stocks is 98.9% higher than that of the company.

Icad Inc Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Icad's current stock value. Our valuation model uses many indicators to compare Icad value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Icad competition to find correlations between indicators driving Icad's intrinsic value. More Info.
Icad Inc is rated fourth overall in debt to equity category among related companies. It is currently regarded as number one stock in price to sales category among related companies fabricating about  118.57  of Price to Sales per Debt to Equity. As of August 16, 2022, Price to Sales Ratio is expected to decline to 4.78. Comparative valuation analysis is a catch-all model that can be used if you cannot value Icad by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Icad's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Icad's earnings, one of the primary drivers of an investment's value.

Icad Beta Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Icad's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Icad could also be used in its relative valuation, which is a method of valuing Icad by comparing valuation metrics of similar companies.
Icad is currently under evaluation in beta category among related companies.

Icad Current Valuation Drivers

We derive many important indicators used in calculating different scores of Icad from analyzing Icad's financial statements. These drivers represent accounts that assess Icad's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Icad's important valuation drivers and their relationship over time.
201720182019202020212022 (projected)
Net Income Per Employee(119.8 K)(92.96 K)(98.2 K)(154.05 K)(82.08 K)(88.56 K)
Revenue Per Employee236.15 K264.13 K227.1 K259.8 K245.53 K282.52 K
Average Assets35.47 M29.1 M39.29 M47.28 M67.5 M58.43 M
Earnings Before Interest Taxes and Depreciation Amortization EBITDA(12.66 M)(7.76 M)(12.05 M)(16.52 M)(10.55 M)(11.38 M)
Earnings Before Interest Taxes and Depreciation Amortization USD(12.66 M)(7.76 M)(12.05 M)(16.52 M)(10.55 M)(11.38 M)
Earnings before Tax(14.27 M)(8.97 M)(13.51 M)(17.57 M)(11.24 M)(12.13 M)
Average Equity20.56 M9.72 M7.18 M24.36 M50.18 M39.66 M
Enterprise Value51.51 M61.34 M153.32 M290.71 M146.27 M137.29 M
Free Cash Flow(7.73 M)(4.17 M)(7.4 M)(7.45 M)(9.97 M)(10.23 M)
Invested Capital6.36 M9.5 M20.54 M11.15 M5.06 M6.49 M
Invested Capital Average3.29 M5.82 M16.51 M10.77 M8.18 M8.24 M
Market Capitalization56.8 M62.06 M150.42 M303.51 M180.79 M160.4 M
Tangible Asset Value21.84 M21.82 M32.2 M46.33 M53.15 M45.72 M
Working Capital9.14 M7.97 M10.36 M25.55 M35.34 M38.13 M
Let's try to break down what Icad's beta means in this case. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Icad will likely underperform.

Icad Fundamentals

About Icad Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Icad Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Icad using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Icad Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for 2022
Deferred Revenue6.1 M6.3 M
Cost of Revenue9.4 M8.8 M
Revenues33.6 M31.1 M
Revenue to Assets 0.54  0.54 
Revenue Per Employee245.5 K282.5 K
iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire. Icad operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 136 people.

Icad Investors Sentiment

The influence of Icad's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Icad. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.
Investor biases related to Icad's public news can be used to forecast risks associated with investment in Icad. The trend in average sentiment can be used to explain how an investor holding Icad can time the market purely based on public headlines and social activities around Icad Inc. Please note that most equiteis that are difficult to arbitrage are affected by market sentiment the most.
Icad's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Icad's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Icad's news discussions. The higher the estimate score, the more favorable is the investor's outlook on Icad.

Icad Implied Volatility

    
  510.2  
Icad's implied volatility exposes the market's sentiment of Icad Inc stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Icad's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Icad stock will not fluctuate a lot when Icad's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Icad in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Icad's short interest history, or implied volatility extrapolated from Icad options trading.

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Icad Inc using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see Icad Piotroski F Score and Icad Altman Z Score analysis. Note that the Icad Inc information on this page should be used as a complementary analysis to other Icad's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Money Managers module to screen money managers from public funds and ETFs managed around the world.

Complementary Tools for Icad Stock analysis

When running Icad Inc price analysis, check to measure Icad's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Icad is operating at the current time. Most of Icad's value examination focuses on studying past and present price action to predict the probability of Icad's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Icad's price. Additionally, you may evaluate how the addition of Icad to your portfolios can decrease your overall portfolio volatility.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Is Icad's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Icad. If investors know Icad will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Icad listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
81.4 M
Quarterly Revenue Growth YOY
-0.032
Return On Assets
-0.13
Return On Equity
-0.28
The market value of Icad Inc is measured differently than its book value, which is the value of Icad that is recorded on the company's balance sheet. Investors also form their own opinion of Icad's value that differs from its market value or its book value, called intrinsic value, which is Icad's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Icad's market value can be influenced by many factors that don't directly affect Icad's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Icad's value and its price as these two are different measures arrived at by different means. Investors typically determine Icad value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Icad's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.